HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the quarter ending June 30, 2007. Nymox reported a net loss of $1,464,950, or $0.05 per share for the second quarter of 2007, compared to $1,360,621, or $0.05 per share for same period in 2006. Product sales amounted to $215,789 for the six months ending June 30, 2007, compared to $212,949 for the same period in 2006. The weighted average number of common shares at June 30, 2007 was 28,759,024, compared to 27,327,305 at June 30, 2006.
